Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.
暂无分享,去创建一个
K. Mansfield | M. Jett | I. Lukashevich | R. Hammamieh | R. Carrion | J. Patterson | M. Salvato | K. Brasky | J. Bryant | J. Zapata | Gia E Hoosien | M. Mayda | H. Davis | Anysha E Ticer | C. Cairo | Marco Goicochea
[1] K. Campbell,et al. Basolateral Entry and Release of New and Old World Arenaviruses from Human Airway Epithelia , 2008, Journal of Virology.
[2] C. Roth,et al. New opportunities for field research on the pathogenesis and treatment of Lassa fever. , 2008, Antiviral research.
[3] G. Poland,et al. Flu myths: dispelling the myths associated with live attenuated influenza vaccine. , 2008, Mayo Clinic proceedings.
[4] S. Peel,et al. Blood genomic profiles of exposures to Venezuelan equine encephalitis in Cynomolgus macaques (Macaca fascicularis) , 2007, Virology Journal.
[5] Rasha Hammamieh,et al. Monkey Model for Lassa Fever Early Blood Profiles of Virus Infection in a Supplemental Material , 2007 .
[6] I. Lukashevich,et al. A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity. , 2007, Vaccine.
[7] S. Tardif,et al. Lassa Virus Infection in Experimentally Infected Marmosets: Liver Pathology and Immunophenotypic Alterations in Target Tissues , 2007, Journal of Virology.
[8] I. Lukashevich,et al. Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses , 2007, Virus Genes.
[9] Igor S. Lukashevich and Maria S. Salvato. Lassa Virus Genome , 2006 .
[10] M. Wolfe,et al. Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.
[11] V. Deubel,et al. A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. , 2006, Virology.
[12] P. Darlu,et al. Very virulent infectious bursal disease virus: reduced pathogenicity in a rare natural segment-B-reassorted isolate. , 2006, The Journal of general virology.
[13] I. Lukashevich,et al. A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses , 2005, Journal of Virology.
[14] B. Mothé,et al. Development of a New Vaccine for the Prevention of Lassa Fever , 2005, PLoS medicine.
[15] I. Lukashevich,et al. Ribonucleic acids of Machupo and Lassa viruses , 2005, Archives of Virology.
[16] K. Mansfield,et al. GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology. , 2004, The Journal of general virology.
[17] J. McCormick,et al. Lassa fever vaccine , 2004, Expert review of vaccines.
[18] A. Hoerauf,et al. Old and New World arenaviruses share a highly conserved epitope in the fusion domain of the glycoprotein 2, which is recognized by Lassa virus-specific human CD4+ T-cell clones. , 2004, Virology.
[19] Lassa fever: epidemiology, clinical features, and social consequences , 2004, BMJ : British Medical Journal.
[20] I. Lukashevich,et al. Arenavirus-Mediated Liver Pathology: Acute Lymphocytic Choriomeningitis Virus Infection of Rhesus Macaques Is Characterized by High-Level Interleukin-6 Expression and Hepatocyte Proliferation , 2003, Journal of Virology.
[21] P. Jahrling,et al. Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus , 2002, Journal of medical virology.
[22] Philip K. Russell,et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. , 2002, JAMA.
[23] P. Jahrling,et al. Individual and Bivalent Vaccines Based on Alphavirus Replicons Protect Guinea Pigs against Infection with Lassa and Ebola Viruses , 2001, Journal of Virology.
[24] N. Seidah,et al. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Hutwagner,et al. Effective Vaccine for Lassa Fever , 2000, Journal of Virology.
[26] A. Hoerauf,et al. Characterization of Human CD4+ T-Cell Clones Recognizing Conserved and Variable Epitopes of the Lassa Virus Nucleoprotein , 2000, Journal of Virology.
[27] I. Lukashevich,et al. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5' End. , 1997, Virology.
[28] I. Lukashevich,et al. The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 kDa protein with monospecific antiserum. , 1997, The Journal of general virology.
[29] D. Brown,et al. Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.
[30] I. Lukashevich. Generation of reassortants between African arenaviruses. , 1992, Virology.
[31] S. Wilson,et al. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. , 1991, Virus research.
[32] J. Saluzzo,et al. Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. , 1990, Vaccine.
[33] J. McCormick,et al. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. , 1986, Virology.
[34] J. McCormick,et al. Lassa virus hepatitis: a study of fatal Lassa fever in humans. , 1986, The American journal of tropical medicine and hygiene.
[35] A. Anusz. [Lassa fever]. , 1981, Pielegniarka i polozna.
[36] T. Monath,et al. Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone , 1974, Science.
[37] J. Frame,et al. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.